Vanda Pharmaceuticals Inc
Research Vanda Pharmaceuticals Inc (VNDA) on Bullrun: market cap USD 328.87M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVNDA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 328.87M
- Financial periodQ2 2026
- RevenueUSD 50.53M
- Net income-USD 62.51M
- Free cash flow-USD 31.26M
- Gross margin93.0%
Valuation Snapshot
latest market cap is USD 328.87M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 216.11M | -USD 220.50M | -USD 110.44M | 94.0% | -3.74 | USD 84.85M | USD 12.62M | USD 327.19M |
| FY2024 | USD 198.77M | -USD 18.90M | -USD 16.25M | 94.3% | -0.33 | USD 102.32M | USD 12.36M | USD 538.55M |
| FY2023 | USD 192.64M | USD 2.50M | USD 12.42M | 92.3% | 0.04 | USD 135.82M | USD 9.40M | USD 544.91M |
| FY2022 | USD 254.38M | USD 6.30M | USD 31.31M | n/a | 0.11 | USD 135.03M | USD 11.53M | USD 527.20M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 328.87M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 521.28M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 279.31M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 242.79M | 20.1 | n/a | n/a |
| 2022 | 2022-12-30 | USD 418.20M | 67.2 | n/a | n/a |
| 2021 | 2021-12-31 | USD 877.09M | 27.1 | n/a | n/a |
About Vanda Pharmaceuticals Inc
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing forms of multiple sclerosis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Vanda Pharmaceuticals Inc's market cap?
Vanda Pharmaceuticals Inc's market capitalization is USD 328.87M.
What does Vanda Pharmaceuticals Inc do?
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing forms of multiple sclerosis; and NEREUSTM for preventing vomiting induced by motion.